Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice-Reference-Cited by-同舟云学术

Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice

Published:2021-10-20 Issue: Volume: Page:
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J Appl Toxicol

Author:

Desai Varsha G.¹^ORCID,Vijay Vikrant¹,Han Tao¹,Moland Carrie L.¹,Phanavanh Bounleut¹,Lee Taewon²,Davis Kelly J.³,Muskhelishvili Levan³,Stine Kimo C.⁴,Fuscoe James C.¹

Affiliation:

1. Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research U.S. Food and Drug Administration Jefferson Arkansas USA

2. Division of Applied Mathematical Sciences Korea University Sejong South Korea

3. Toxicologic Pathology Associates National Center for Toxicological Research Jefferson Arkansas USA

4. Department of Pediatrics Pediatric Hematology‐Oncology, Arkansas Children's Hospital Little Rock Arkansas USA

Publisher

Wiley

Subject

Toxicology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jat.4256

Reference37 articles.

1. Sarcoplasmic Reticulum Genes are Selectively Down-regulated in Cardiomyopathy Produced by Doxorubicin in Rabbits

2. Calcium Cycling and Signaling in Cardiac Myocytes

3. Anthracycline-Induced Cardiomyopathy

4. Center for Drug Evaluation and Research (CDER).(2005).Guidance for Industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers.https://www.fda.gov/media/72309/download

5. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Drug Delivery with Oil‐in‐Water Nanoemulsions: Stability and Sustained Release of Doxorubicin;Macromolecular Rapid Communications;2024-07-31

2. Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity;Frontiers in Cardiovascular Medicine;2024-05-16

3. Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity;Reviews in Cardiovascular Medicine;2023-11-27

4. Anthracycline‑induced delayed‑onset cardiac toxicity: A case report and literature review;Experimental and Therapeutic Medicine;2023-09-13

5. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity;2023-07-18